Form D · Venture Capital Fund
SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP
Dublin 2, L2 · CIK 0001998268
Offering snapshot reported Oct 26, 2023 · SEC filing
- Reported sold
- $1.01M Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $113K Reported outside-investor minimum
- First sale
- Dec 20, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 26, 2023 | Initial | $1,014,570 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-495673
Source: Form D, filed Oct 26, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Duignan | Director, Executive |
| Jennifer Mcmahon | Director |
| Bruno Montanari | Director |
| Alan O'connell | Director |
| Daniel O'mahony | Director |
| Peter Sandys | Director |
| N/A Seroba Life Sciences (Gp Iv) Limited | Director, Executive |
| N/A Seroba Life Sciences Management Limited | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
C/O Seroba Life Sciences (Gp Iv) Limited Mount Herbert Ct, 34 Upper Mount St
Dublin 2, L2, D02 FT72
Dublin 2, L2, D02 FT72